Treatment of Discoid Lupus Erythematosus with Localized Skin Lesions and No Severe or Widespread Involvement
This protocol covers patients with localized skin lesions of discoid lupus erythematosus who have no severe or widespread skin involvement, no risk of scarring, and no risk of progression to systemic disease. The patient is neither pregnant nor breastfeeding.
Clinical situation
Localized skin lesions
No severe or widespread involvement
No scarring risk
No systemic progression risk
Not pregnant
Not breastfeeding
Treatment approach (partial)
For this localized presentation, topical treatment forms the cornerstone of management. In cases where an additional oral agent is needed, the protocol specifies the use of quinacrine — either in combination with a standard antimalarial or, when contraindications apply, as monotherapy. The full sequencing, thresholds, and specifications remain in the complete protocol.
References
Topical corticosteroids are the mainstay in the treatment of localized CLE being effective in all subtypes.
In refractory cases, we recommend to add quinacrine to either HCQ or CQ.
In cases of contraindication for HCQ or CQ (e.g., retinopathy), monotherapy with quinacrine is recommended.
View source ↗